These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2374330)

  • 1. [Infiltration and tissue concentration of intravesically instilled (2"R)-4'-O-tetrahydropyranyladriamycin or adriamycin in rat bladder tumor induced by BBN].
    Masuda H; Hirai M; Ohtawara Y; Tajima A; Aso Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):577-82. PubMed ID: 2374330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue concentration of intravesically instilled (2"R)-4'-o-tetrahydropyranyl-adriamycin or adriamycin in superficial bladder cancer].
    Saika T; Tsushima T; Nasu Y; Noda M; Akebi N; Kaku S; Takamatsu M; Ohmori H; Uno S; Johsen T
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1206-10. PubMed ID: 8355436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor].
    Masuda H; Hirose J; Suzuki K; Tajima A; Aso Y
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Shock wave therapy of the rabbit VX2 bladder cancer--THP-ADM concentration in the tissue after combination therapy of THP-ADM and shock wave].
    Suzuki K; Orikasa S; Hoshi S; Kuwahara M; Yoshikawa K; Ohyama C; Satou M; Kawamura S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1007-12. PubMed ID: 8345717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluorescence microscopy of the absorption and disappearance of adriamycin through the bladder epithelium in the rat].
    Nakagawa S
    Nihon Hinyokika Gakkai Zasshi; 1990 Sep; 81(9):1302-8. PubMed ID: 2232421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative investigation on use of (2''R)-4'-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors.
    Akaza H; Niijima T; Hisamatsu T; Fujigaki M
    Urology; 1988 Aug; 32(2):141-5. PubMed ID: 3400139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized study of pirarubicin (THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer].
    Kawamura J; Tochigi H; Obata K; Ueda K; Otaguro K; Kuriyama M; Shinoda M; Naruse K; Murase T; Hasegawa Y
    Hinyokika Kiyo; 1992 Mar; 38(3):379-85. PubMed ID: 1523998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor].
    Kobayashi M; Sugaya Y; Yuzawa M; Ochi M; Morita T; Kobayashi Y; Tokue A; Hara Y
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1771-4. PubMed ID: 9757205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histological study on intravesical instillation of Bacillus Calmette Guerin (BCG) and adriamycin for BBN-induced bladder tumor in rats].
    Tanaka S; Kudoh S; Mollik AU; Kudoh T; Kogawa T; Suzuki T
    Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):368-73. PubMed ID: 1564838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental studies on intravesical instillation of 4'-epi-adriamycin for the treatment of bladder cancer].
    Tsushima T
    Hinyokika Kiyo; 1985 Nov; 31(11):1945-56. PubMed ID: 3867286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of retention time of intravesical instillation therapy with pirarubicin (THP)].
    Sugano O; Shoji N; Hatakeyama T; Kato H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1169-74. PubMed ID: 8751805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of intracellular concentration and duration of contamination of pirarubicin and adriamycin in human bladder cancer cell lines and human bladder normal mucosa cell line].
    Saika T; Tsushima T; Nasu Y; Akebi N; Ohmori H
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):905-9. PubMed ID: 8678540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tissue concentration of 4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor].
    Masuda H; Hirose J; Ohtawara Y; Suzuki K; Tajima A; Aso Y; Shomura T; Kawamura K
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1975-9. PubMed ID: 4051513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravesical instillation of antitumor drugs in the development of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumors in rats.
    Suzuki T; Imai K; Takezawa Y; Tsuji H; Yamanaka H; Suzuki K
    Hinyokika Kiyo; 1989 Feb; 35(2):247-51. PubMed ID: 2735235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tissue concentration of (2"R)-4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor (second report)].
    Masuda H; Hirose J; Ohtawara Y; Suzuki K; Tajima A; Aso Y; Hiramatsu K; Shomura T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2912-6. PubMed ID: 3662546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethylsulfoxide enhances the absorption of chemotherapeutic drug instilled into the bladder.
    Hashimoto H; Tokunaka S; Sasaki M; Nishihara M; Yachiku S
    Urol Res; 1992; 20(3):233-6. PubMed ID: 1615585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
    Li Q; Xu T; Wang XF
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
    Szende B; Jeney A; Institoris L
    Acta Morphol Hung; 1992; 40(1-4):187-93. PubMed ID: 1365762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.